-       Report 
   - April 2025
    -  78 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                 -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2382EUR$2,650USD£2,089GBP 
                      Methylpiperazine is a pharmaceutical intermediate used in the production of active pharmaceutical ingredients (APIs). It is a cyclic amine compound with a wide range of applications in the pharmaceutical industry, including the synthesis of antifungal, antiviral, and anti-inflammatory drugs. It is also used in the production of contrast agents for medical imaging. Methylpiperazine is a versatile compound that can be used in a variety of reactions, including condensation, alkylation, and    acylation.
Methylpiperazine is produced by a number of companies, including Merck KGaA, Sigma-Aldrich, and Alfa Aesar. It is also available from specialty chemical suppliers such as TCI Chemicals and ABCR GmbH. Additionally, there are a number of manufacturers in India, China, and other countries that produce methylpiperazine for the global market. Show Less   Read more